An interventional study of Robot-assisted laparoscopic extended right colectomy in Colorectal Cancer, sponsored by Vejle Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by Vejle Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Colorectal Neoplasms by Vejle Hospital — 5 open to participants now, 6 under way, none of them phase 3. Colorectal Neoplasms · Vejle Hospital.
Among the 17 studies in Colorectal Neoplasms by Vejle Hospital, this one is the 11th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2020, is one of 5 with no phase, and was the 11th registered.
6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.
Browse Colorectal Neoplasms studies →5 of the 17 studies in Colorectal Neoplasms by Vejle Hospital are open now, in 1 country. Recruiting first, the newest first:
Vejle Hospital · Sites in Denmark
Ages 18+
Vejle Hospital · Sites in Denmark
Ages 50–74
Vejle Hospital · Sites in Denmark
Ages 18+
Vejle Hospital
Ages 18+
By country, each count listing its studies:
Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 76 across 4,811 interventional studies indexed under Colorectal Neoplasms.
Median enrollment 77 across the 14 interventional studies, 2,000 across the 3 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Vejle Hospital is the lead sponsor of 95 studies on the registry; 13 are open to participants now.
3 of the studies in Colorectal Neoplasms by Vejle Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04190589Vejle HospitalProspective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer | 2026-12 |
| NCT07201194Vejle HospitalHolistic Acupuncture for Patients With Chemotherapy Induced Nausea | 2027-04 |
| NCT06714318Vejle HospitalSMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening | 2027-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 17 studies in Colorectal Neoplasms by Vejle Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.
Complete mesocolic excision with central vascular ligation (CME) is an improvement of surgical technique in the operation for colonic cancer suggested to increase long-term survival. The concept was originally developed for open surgery by W. Hohenberger in Erlangen with excellent survival rates. However, if the tumor is located in the transverse colon or near the right colonic flexure, the procedure is particularly technically demanding, and for that reason most surgeons still prefer to do it by open operation (laparotomy) instead of the minimally invasive approach (laparoscopy) presently recommended for colonic cancer surgery. The advent of robotic surgery has improved the dexterity of instruments used in laparoscopic surgery and pushed the limits of what is possible with a minimally invasive approach. Since minimally invasive surgery is associated with better outcomes in terms of postoperative morbidity, pain, length of stay etc., it would be highly desirable if CME surgery could be done by robot-assisted laparoscopic operation instead of the current open approach. The current single-center study is proposed to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Robot-assisted extended right colectomy
Device: Robot-assisted laparoscopic extended right colectomy
An extended right hemicolectomy with total mesocolic excision and meticulous central dissection as described by Hohenberger will be performed with the DaVinci Xi robot by one of two dedicated surgeons
Also known as: DaVinci Xi
Plane of dissection
As judged by pathologist (mesocolic/intramesocolic/intramuscular)
Time frame: 30 days
Lymph node count
Number of nodes in specimen, as determined by pathologist
Time frame: 30 days
Complications
Postoperative complications, graded by Clavien-Dindo
Time frame: 30 days
Reinterventions
Reinterventions under anesthesia before discharge from hospital
Time frame: 30 days
Length of stay
Days from operation to discharge from hospital
Time frame: 30 days
Readmissions
Readmissions to hospital 1-30 days after initial discharge
Time frame: 30 days
Operation time
Minutes from first incision to final stitch
Time frame: intraoperative
Conversion rate
Percentage of conversions from robotic to open surgery
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
Started May 2020 (actual). Primary completion is estimated for Dec 2026, 79 months after the start.
Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 79 months is above that.
Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vejle Hospital